🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2010-01
Trial ID
NCT01065012
The primary purpose of the study is to evaluate the efficacy (overall respo...
Status
Completed
Location
Multiple Locations
Start Date
2003-05-27
Trial ID
NCT00783393
Treatments Being Tested
A follow-up study to evaluate the safety and clinical outcomes of patients ...
Status
Terminated
Location
University of Minnesota
Start Date
2019-05-21
Trial ID
NCT04008849
Treatments Being Tested
To evaluate the long-term safety of RGL-193 capsid injection in patients wi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-15
Trial ID
NCT07279844
Treatments Being Tested
The objective of this study is to demonstrate the efficacy of Dysport for t...
Status
Completed
Location
Peking University First Hospital
Start Date
2015-04
Trial ID
NCT02450526
Treatments Being Tested
The CEDUR registry systematically collects real-world data on inflammatory ...
Status
Recruiting
Location
ImmunoRegister gUG
Start Date
2018-05-03
Trial ID
NCT07319442
The purpose of this trial is to investigate the safety and tolerability of ...
Status
Completed
Location
Multiple Locations
Start Date
2009-06-17
Trial ID
NCT00903786
Treatments Being Tested
The primary objective of this study is to assess the safety and outcomes of...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-06-01
Trial ID
NCT02292784
This study is being done to determine the long-term safety and possible ben...
Status
Terminated
Location
Retina Foundation of the Southwest
Start Date
2014-04
Trial ID
NCT02137915
Treatments Being Tested
The purpose of this study is to assess long-term side effects from subjects...
Status
Active Not Recruiting
Location
Blood and Marrow Transplant Program
Start Date
2022-02-14
Trial ID
NCT04911478
Treatments Being Tested